Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes

Clinical Endocrinology

Volumn 80, Issue 6, 2014, Pages 825-833

  Kim, So Hun ^a   Lee, Seung Hwan ^b   Ahn, Ki Yong ^b   Lee, Dong Hoon ^b   Suh, Young Ju ^a   Cho, Soon Gu ^a   Choi, Yun Jin ^a   Lee, Dae Hyung ^a   Lee, Seung Youn ^a   Hong, Seong Bin ^a   Kim, Yong Seong ^a   Jeon, Justin Y ^b   Nam, Moonsuk ^a  

^a Inha University School of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CHEMERIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; CHEMOKINE RECEPTOR; CMKLR1 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; INSULIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ADULT; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; ANALYSIS; ANTHROPOMETRY; BLOOD; DIET; HOMEOSTASIS; LIFESTYLE; METABOLISM; MIDDLE AGED; RISK FACTOR; TREATMENT OUTCOME;

ACUTE-PHASE PROTEINS; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIET; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIFE STYLE; LIPOCALINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; PROTO-ONCOGENE PROTEINS; RECEPTORS, CHEMOKINE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84899587049     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12249     Document Type: Article

References (35)

1. Rosen, E.D., &, Spiegelman, B.M., (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature, 444, 847-853.
2. Ronti, T., Lupattelli, G., &, Mannarino, E., (2006) The endocrine function of adipose tissue: an update. Clinical Endocrinology, 64, 355-365.
3. Hotamisligil, G.S., (2006) Inflammation and metabolic disorders. Nature, 444, 860-867.
4. Bluher, M., (2009) Adipose tissue dysfunction in obesity. Experimental and Clinical Endocrinology & Diabetes, 117, 241-250.
5. Ernst, M.C., &, Sinal, C.J., (2010) Chemerin: at the crossroads of inflammation and obesity. Trends in Endocrinology and Metabolism, 21, 660-667.
6. MacDougald, O.A., &, Burant, C.F., (2007) The rapidly expanding family of adipokines. Cell Metabolism, 6, 159-161.
7. Bozaoglu, K., Bolton, K., McMillan, J., et al,. (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology, 148, 4687-4694.
8. Sell, H., Divoux, A., Poitou, C., et al,. (2010) Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. Journal of Clinical Endocrinology and Metabolism, 95, 2892-2896.
9. Weigert, J., Neumeier, M., Wanninger, J., et al,. (2010) Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical Endocrinology (Oxford), 72, 342-348.
10. Lehrke, M., Becker, A., Greif, M., et al,. (2009) Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. European Journal of Endocrinology, 161, 339-344.
11. Chakaroun, R., Raschpichler, M., Kloting, N., et al,. (2012) Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism: Clinical and Experimental, 61, 706-714.
12. Venojärvi, M., Wasenius, N., Manderoos, S., et al,. (2013) Nordic walking decreased circulating chemerin and leptin concentrations in middle-aged men with impaired glucose regulation. Annals of Medicine, 45, 162-170.
13. Pi-Sunyer, X., Blackburn, G., Brancati, F.L., et al,. (2007) Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care, 30, 1374-1383.
14. Kim, S.H., Lee, S.J., Kang, E.S., et al,. (2006) Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus. Metabolism: Clinical and Experimental, 55, 1053-1059.
15. Roberts, C.K., Won, D., Pruthi, S., et al,. (2006) Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men. Diabetes Research and Clinical Practice, 73, 249-259.
16. Erbay, E., Cao, H., &, Hotamisligil, G.S., (2007) Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome. Current Atherosclerosis Reports, 9, 222-229.
17. Li, C., &, Chan, Y.R., (2011) Lipocalin 2 regulation and its complex role in inflammation and cancer. Cytokine, 56, 435-441.
18. Wang, Y., Lam, K.S., Kraegen, E.W., et al,. (2007) Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clinical Chemistry, 53, 34-41.
19. Rasouli, N., &, Kern, P.A., (2008) Adipocytokines and the metabolic complications of obesity. Journal of Clinical Endocrinology and Metabolism, 93, S11-S18.
20. Genuth, S., Alberti, K.G., Bennett, P., et al,. (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 26, 3160-3167.
21. I.O.T.F. (2000) Asia-Pacific Perspective: Redefining Obesity and its Treatment. Western Pacific Region. IOTF, Sydney.
22. Yoo, J.S., Lee, S.J., Lee, H.C., et al,. (2004) The effects of short term comprehensive life style modification program on glycemic metabolism, lipid metabolism and body composition in type 2 diabetes mellitus. Taehan Kanho Hakhoe Chi, 34, 1277-1287.
23. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al,. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
24. Matsuda, M., &, DeFronzo, R.A., (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 22, 1462-1470.
25. Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., et al,. (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 35, 1364-1379.
26. Norris, S.L., Zhang, X., Avenell, A., et al,. (2005) Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Systematic Review, 18, CD004095.
27. Wing, R.R., (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Archives of Internal Medicine, 170, 1566-1575.
28. Koiou, E., Tziomalos, K., Katsikis, I., et al,. (2012) Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome. Gynecological endocrinology, 28, 20-24.
29. Choi, K.M., Kim, T.N., Yoo, H.J., et al,. (2009) Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women. Clinical Endocrinology, 70, 569-574.
30. Ress, C., Tschoner, A., Engl, J., et al,. (2010) Effect of bariatric surgery on circulating chemerin levels. European Journal of Clinical Investigation, 40, 277-280.
31. Kralisch, S., Weise, S., Sommer, G., et al,. (2009) Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regulatory Peptides, 154, 102-106.
32. Sell, H., Laurencikiene, J., Taube, A., et al,. (2009) Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes, 58, 2731-2740.
33. Ernst, M.C., Issa, M., Goralski, K.B., et al,. (2010) Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology, 151, 1998-2007.
34. Bozaoglu, K., Segal, D., Shields, K.A., et al,. (2009) Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. Journal of Clinical Endocrinology and Metabolism, 94, 3085-3088.
35. Takahashi, M., Okimura, Y., Iguchi, G., et al,. (2011) Chemerin regulates β-cell function in mice. Scientific Reports, 1, 123.